A detailed history of Russell Investments Group, Ltd. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,566 shares of RXST stock, worth $46,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,566
Previous 95,978 98.37%
Holding current value
$46,682
Previous $4.74 Million 98.88%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$33.66 - $54.73 $3.18 Million - $5.17 Million
-94,412 Reduced 98.37%
1,566 $53,000
Q3 2024

Nov 13, 2024

SELL
$40.78 - $57.04 $2.55 Million - $3.56 Million
-62,417 Reduced 39.41%
95,978 $4.74 Million
Q2 2024

Aug 08, 2024

SELL
$50.42 - $64.29 $462,956 - $590,310
-9,182 Reduced 5.48%
158,395 $9.53 Million
Q1 2024

May 08, 2024

SELL
$35.51 - $57.92 $2.15 Million - $3.51 Million
-60,646 Reduced 26.57%
167,577 $8.64 Million
Q4 2023

Feb 05, 2024

SELL
$20.91 - $40.9 $24,046 - $47,035
-1,150 Reduced 0.5%
228,223 $9.2 Million
Q3 2023

Nov 13, 2023

SELL
$27.05 - $33.37 $1.53 Million - $1.89 Million
-56,581 Reduced 19.79%
229,373 $6.4 Million
Q2 2023

Aug 10, 2023

BUY
$16.37 - $28.9 $3.46 Million - $6.12 Million
211,666 Added 284.93%
285,954 $8.24 Million
Q1 2023

May 09, 2023

BUY
$12.58 - $16.68 $62,774 - $83,233
4,990 Added 7.2%
74,288 $1.24 Million
Q4 2022

Feb 08, 2023

BUY
$9.93 - $14.2 $121,225 - $173,353
12,208 Added 21.38%
69,298 $878,000
Q3 2022

Nov 04, 2022

BUY
$11.19 - $15.85 $31,824 - $45,077
2,844 Added 5.24%
57,090 $684,000
Q2 2022

Jul 29, 2022

BUY
$10.61 - $16.66 $575,550 - $903,738
54,246 New
54,246 $762,000
Q1 2022

May 05, 2022

SELL
$8.97 - $14.03 $391,522 - $612,381
-43,648 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$9.52 - $13.81 $415,528 - $602,778
43,648 New
43,648 $490,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $824M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.